Healthcare Services

Actinic Keratosis Market Global Report 2026 Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Actinic Keratosis Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The actinic keratosis market size has experienced significant expansion in recent years. It is anticipated to increase from $8.42 billion in 2025 to $8.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.8%. This historical growth can be attributed to factors such as rising UV exposure and sunburn incidence, the limited availability of effective topical agents, increasing skin cancer prevalence, the expansion of dermatology infrastructure, and the adoption of conventional surgical procedures.

The market for actinic keratosis is projected to experience substantial expansion over the coming years, reaching $11.06 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.6%. This anticipated growth during the forecast period is largely driven by factors such as the development of sophisticated photodynamic therapies, a rise in the application of combined topical and procedural treatments, the broadening of hospital and dermatology clinic networks, heightened consumer awareness regarding early intervention, and the introduction of novel homecare treatment options. Key trends observed within the forecast period encompass an increasing emphasis on sun protection and overall skin health awareness, the growing acceptance of non-invasive photodynamic therapy, an increase in the use of topical therapeutics for early-stage actinic keratosis, the expansion of both dermatology clinics and homecare treatment solutions, and a growing inclination towards combination therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

What Key Drivers Are Influencing The Growth Of The Actinic Keratosis Market?

The actinic keratosis market is projected to expand due to the increasing incidence of severe sunburns. These are intense skin burns, a consequence of excessive exposure to ultraviolet (UV) radiation, which manifest as redness, pain, swelling, and occasionally blistering. Factors contributing to sunburns include prolonged exposure to ultraviolet (UV) radiation, inadequate sun protection measures, greater participation in outdoor activities during peak UV hours, and rising temperatures linked to climate change. Sunburns lead to actinic keratosis by causing DNA damage in skin cells through ultraviolet (UV) radiation, which generates mutations that impair normal cell function, thereby fostering the development of precancerous lesions, particularly with recurrent or extended sun exposure. For instance, in May 2024, according to Melanoma Focus, a UK-based charity, in 2022-23, there were 201 hospital admissions due to sunburn, encompassing 89 children and 25 babies under one year old. The charity additionally found that 66% of UK adults aged 16-65 remembered getting sunburned as children, with 65% of them experiencing severe sunburn with blisters at least once. This number rose to 77% for those with light, pale, or white skin. Consequently, the expanding occurrence of severe sunburns is propelling the growth of the actinic keratosis market.

What Major Segment Divisions Exist Within The Actinic Keratosis Market?

The actinic keratosis market covered in this report is segmented –

1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies

3) By End-User: Hospitals, Dermatology Clinics, Homecare Settings, Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac

2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy, Combination Therapies

How Are Trends Shaping The Direction Of The Actinic Keratosis Market?

Companies operating in the actinic keratosis market are intensely focused on developing topical ointments. These efforts aim to effectively target and eliminate precancerous lesions, decrease recurrence rates, and boost patient compliance by offering shorter treatment durations and improved safety profiles. Topical ointments are medicinal creams or gels applied directly to the affected skin, containing active ingredients like tirbanibulin, which function by addressing abnormal keratinocytes to manage precancerous lesions. For example, in June 2024, Almirall SA, a Spain-based biopharmaceutical company, received approval from the US Food and Drug Administration (FDA) for a supplemental new drug application (sNDA). This approval expands the treatable area for its drug, Klisyri, to up to 100 cm2. Klisyri (tirbanibulin) 1% ointment acts as a microtubule inhibitor, designed to prevent the proliferation of abnormal keratinocytes, thereby effectively reducing the quantity and size of precancerous lesions for the treatment of actinic keratosis (AK) on the face or scalp.

Which Companies Are Leading Innovation In The Actinic Keratosis Market?

Major companies operating in the actinic keratosis market are Galderma SA, LEO Pharma A/S, Almirall S.A., Bausch Health Companies Inc., Perrigo Company plc, Pfizer Inc, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Novartis AG, GSK plc, Amgen Inc., Incyte Corporation, Aclaris Therapeutics Inc., Biofrontera AG, Hill Dermaceuticals Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Viatris Inc.

Read the full actinic keratosis market report here:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Actinic Keratosis Market?

North America was the largest region in the actinic keratosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Actinic Keratosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp

Browse Through More Reports Similar to the Global Actinic Keratosis Market 2026, By The Business Research Company

neurotrophic keratitis treatment global market report

https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report

scleroderma global market report

https://www.thebusinessresearchcompany.com/report/scleroderma-global-market-report

keloids treatment global market report

https://www.thebusinessresearchcompany.com/report/keloids-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795